Clal Biotechnology Industries Ltd (CBI) — Cash Flow Reinvestment Rate

Latest as of September 2020: 4.61x

Clal Biotechnology Industries Ltd (CBI) has a Cash Flow Reinvestment Rate of 4.61x as of September 2020, reinvesting ILA5.10 Million (capex ILA806.00K plus investments ILA-4.29 Million) from operating cash flow of ILA1.10 Million. See Clal Biotechnology Industries Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

4.61x

(Capex + Investments) / Operating CF

Total Reinvested

ILA5.10 Million

Capex + Investments

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Clal Biotechnology Industries Ltd Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Clal Biotechnology Industries Ltd across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Clal Biotechnology Industries Ltd.

Annual Cash Flow Reinvestment Rate for Clal Biotechnology Industries Ltd (2019–2019)

Year-by-year capital reinvestment analysis for Clal Biotechnology Industries Ltd. See financial agility of Clal Biotechnology Industries Ltd to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2019	0.89x	ILA24.14 Million	ILA27.03 Million	ILA2.83 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow